NORBERTO
ORTEGO CENTENO

CATEDRÁTICO DE UNIVERSIDAD

Foto de NORBERTO

Foto de Hospital de Fuenlabrada

Hospital de Fuenlabrada

Fuenlabrada, España

Publications in collaboration with researchers from Hospital de Fuenlabrada (6)

2024

Exposure to different occupational chemicals and clinical phenotype of a cohort of patients with systemic sclerosis
Autoimmunity Reviews

2021

Corrigendum to ‘Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation’ [AUTREV 19-5 (2020) 102507] (Autoimmunity Reviews (2020) 19(5), (S1568997220300598), (10.1016/j.autrev.2020.102507))
Autoimmunity Reviews
Immune thrombocytopenia and COVID-19: Case report and review of literature
Lupus, Vol. 30, Núm. 9, pp. 1515-1521

2020

Spanish scleroderma risk score (RESCLESCORE) to predict 15-year all-cause mortality in scleroderma patients at the time of diagnosis based on the RESCLE cohort: Derivation and internal validation
Autoimmunity Reviews, Vol. 19, Núm. 5

2016

Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies
Seminars in Arthritis and Rheumatism, Vol. 45, Núm. 4, pp. 391-399

2011

Rates of, and risk factors for, severe infections in patients with systemic autoimmune diseases receiving biological agents off-label
Arthritis Research and Therapy, Vol. 13, Núm. 4